Lv21
170 积分 2024-12-10 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial
7小时前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
1个月前
已完结
As Ozempic's Popularity Soars, Here's What to Know About Semaglutide and Weight Loss
2个月前
已完结
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
2个月前
已关闭
Lipoprotein(a) - From Biomarker to Therapy: A Review for the Clinician
2个月前
已完结
Does Receptor Balance Matter? - Comparing the Efficacies of the Dual Amylin and Calcitonin Receptor Agonists Cagrilintide and KBP-336 on Metabolic Parameters in Preclinical Models. Biomed Pharmacother
3个月前
已完结
The unexpected role of GIP in transforming obesity treatment
4个月前
已完结
Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity
4个月前
已完结
The unexpected role of GIP in transforming obesity treatment
4个月前
已完结
A Mechanistic Rationale for Incretin-Based Therapeutics in the Management of Obesity
4个月前
已完结
皖公网安备34019202002308
